{
      "userid": 1,
      "official_url": "https://mjstjournal.com/index.php/mjst/article/view/6720",
      "subjects": [
        "epilepsy; antiseizure medicines (ASMs); new-generation anticonvulsants; brivaracetam; lacosamide; perampanel; cenobamate; monitoring."
      ],
      "ispublished": "pub",
      "date_type": "published",
      "metadata_visibility": "show",
      "note": "Imported from MJST Journal (OAI id oai:ojs.pkp.sfu.ca:article/6720)",
      "uri": "https://arxiv.universalpublishings.com/id/eprint/65490",
      "date": "2026-02-02",
      "type": "article",
      "full_text_status": "none",
      "id_number": "oai:ojs.pkp.sfu.ca:article/6720",
      "keywords": "epilepsy; antiseizure medicines (ASMs); new-generation anticonvulsants; brivaracetam; lacosamide; perampanel; cenobamate; monitoring.",
      "dir": "disk0/00/06/54/90",
      "sword_depositor": 1,
      "lastmod": "2026-05-26 15:55:43",
      "publication": "Multidisciplinary Journal of Science and Technology",
      "eprint_status": "archive",
      "title": "NEW-GENERATION ANTICONVULSANTS IN EPILEPSY: PRACTICAL SELECTION AND SAFETY MONITORING",
      "status_changed": "2026-05-26 15:55:43",
      "abstract": "Epilepsy is a chronic neurological disorder characterized by recurrent seizures. The main goals of treatment are to control seizures, minimize adverse effects, and improve patients' quality of life. In recent years, new-generation antiseizure medicines (ASMs) - brivaracetam, lacosamide, perampanel, cenobamate, cannabidiol, and fenfluramine - have stood out due to diversification of mechanisms and additional clinical options in some pharmacoresistant cases. This article, using an evidence-informed review approach, summarizes indications, efficacy signals, drug-drug interactions, and principles of safety monitoring for these agents. The findings suggest that new-generation ASMs are most often used as add-on therapy; optimal outcomes depend on patient-centered selection tailored to seizure type/syndrome, age and comorbidities, potential drug-drug interactions, and titration rate. In practice, targeted monitoring of treatment retention (persistence), cognitive and psychobehavioral effects, fall risk, and relevant laboratory indicators improves medication safety.",
      "creators": [
        {
          "name": {
            "honourific": null,
            "given": "Choriyev",
            "family": "Shohjahon",
            "lineage": null
          }
        },
        {
          "name": {
            "family": "Ozodbek",
            "lineage": null,
            "given": "Eshqobilov",
            "honourific": null
          }
        }
      ],
      "eprintid": 65490,
      "datestamp": "2026-05-26 15:55:43",
      "rev_number": 1,
      "publisher": "Center for Tech and Media Research"
    }